|
ZNF644 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.926600E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.551200E-01 |
| Normal-vs-Stage2 |
5.653000E-01 |
| Normal-vs-Stage3 |
6.501800E-01 |
| Normal-vs-Stage4 |
9.533000E-01 |
| Stage1-vs-Stage2 |
8.217600E-01 |
| Stage1-vs-Stage3 |
8.719800E-01 |
| Stage1-vs-Stage4 |
3.738000E-01 |
| Stage2-vs-Stage3 |
7.687400E-01 |
| Stage2-vs-Stage4 |
5.378800E-01 |
| Stage3-vs-Stage4 |
5.944600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.105800E-01 |
| Normal-vs-AfricanAmerican |
4.698200E-01 |
| Normal-vs-Asian |
5.602200E-01 |
| Caucasian-vs-AfricanAmerican |
1.304590E-01 |
| Caucasian-vs-Asian |
7.197600E-01 |
| AfricanAmerican-vs-Asian |
3.878400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.596600E-01 |
| Normal-vs-Female |
1.854640E-01 |
| Male-vs-Female |
1.649410E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.150000E-01 |
| Normal-vs-Age(41-60Yrs) |
3.003400E-01 |
| Normal-vs-Age(61-80Yrs) |
7.040800E-01 |
| Normal-vs-Age(81-100Yrs) |
3.797600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.476200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.116600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.383200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.329400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.367620E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.675400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.447600E-02 |
| Normal-vs-Grade 2 |
2.880300E-02 |
| Normal-vs-Grade 3 |
2.650200E-01 |
| Normal-vs-Grade 4 |
2.006000E-01 |
| Grade 1-vs-Grade 2 |
5.545800E-01 |
| Grade 1-vs-Grade 3 |
4.025600E-02 |
| Grade 1-vs-Grade 4 |
3.064200E-02 |
| Grade 2-vs-Grade 3 |
3.360500E-04 |
| Grade 2-vs-Grade 4 |
6.017500E-04 |
| Grade 3-vs-Grade 4 |
5.863800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.102000E-02 |
| Normal-vs-ccB subtype |
5.419400E-01 |
| ccA subtype-vs-ccB subtype |
1.621870E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.368000E-01 |
| Normal-vs-N1 |
6.824800E-01 |
| N0-vs-N1 |
3.941800E-01 |
|
|
